z-logo
open-access-imgOpen Access
Review of the existing maximum residue levels for imazalil according to Article 12 of Regulation ( EC ) No 396/2005
Author(s) -
Brancato Alba,
Brocca Daniela,
De Lentdecker Chloe,
Erdos Zoltan,
Ferreira Lucien,
Greco Luna,
Janossy Judit,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lythgo Christopher,
Medina Paula,
Miron Ileana,
Molnar Tunde,
Nougadere Alexandre,
Pedersen Ragnor,
Reich Hermine,
Sacchi Angela,
Santos Miguel,
Stanek Alois,
Sturma Juergen,
Tarazona Jose,
Theobald Anne,
Vagenende Benedicte,
Verani Alessia,
VillamarBouza Laura
Publication year - 2017
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2017.4977
Subject(s) - european commission , risk assessment , directive , member states , european union , business , pesticide residue , residue (chemistry) , agricultural science , pesticide , microbiology and biotechnology , toxicology , environmental health , chemistry , medicine , biology , international trade , computer science , agronomy , biochemistry , computer security , programming language
According to Article 12 of Regulation ( EC ) No 396/2005, EFSA has reviewed the maximum residue levels ( MRL s) currently established at European level for the pesticide active substance imazalil. To assess the occurrence of imazalil residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/ EEC and under Regulation ( EC ) No 1107/2009, the MRL s established by the Codex Alimentarius Commission as well as the European authorisations reported by Member States (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Some information required by the regulatory framework was missing and a possible chronic and acute risk to consumers was identified. Hence, the consumer risk assessment is considered indicative only, some MRL proposals derived by EFSA still require further consideration by risk managers and measures for reduction of the consumer exposure should also be considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom